UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
of the
SECURITIES EXCHANGE ACT OF 1934
Date of Event Requiring Report: December 22, 2000
NOVAMED, INC.
--------------------------------------------------------
(Exact Name of Registrant as Specified on its Charter)
O-26927 77-0443643
------- ----------
(Commission File Number) (IRS Employer
Identification Number)
NEVADA
------------------------
(State or Other Jurisdiction of Incorporation or Organization)
623 Hoover Street, N.E.
Minneapolis, Minnesota 55413
----------------------------------------
(Address of Principal Executive Offices)
(612) 378 1437
-------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
<PAGE>
--------------------------------------------------------------------------------
ITEM 5. OTHER EVENTS
--------------------------------------------------------------------------------
On December 18, 2000, the Company received the resignation of Dr. Aydin Dogan, a
member of the board of directors and the Company's vice-president. Further, the
Company accepted the resignations of Dr. Howard Bellin and Dr. Franz Schain from
the board of directors on December 20, 2000. Mr. Ruairidh Campbell remains as
the Company's sole director and president.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: December 22, 2000
NovaMed, Inc.
By:/s/ Ruairidh Campbell
-------------------------------
Ruairidh Campbell, President
